Keiko Aoki

发表

Determinants of the HbA1c-lowering effect of sitagliptin when added to ongoing insulin therapy in Japanese patients with type 2 diabetes

H. Kanehara, Y. Bando, Kazuhide Ishikura, 2013, Diabetology International.

Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus

H. Kanehara, Y. Bando, Keiko Aoki, 2016, Journal of clinical & translational endocrinology.

Non-high-density cholesterol level as a predictor of maximum carotid intima-media thickness in Japanese subjects with type 2 diabetes: a comparison with low-density lipoprotein level

H. Kanehara, Y. Bando, Keiko Aoki, 2016, Diabetology International.

Predictive clinical parameters for the hemoglobin A1c-lowering effect of vildagliptin in Japanese patients with type 2 diabetes

H. Kanehara, Y. Bando, Masayuki Yamada, 2014, Diabetology International.

The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis

K. Nakasho, Hideji Nakamura, M. Koga, 2012, Annals of clinical biochemistry.

Obesity may attenuate the HbA1c‐lowering effect of sitagliptin in Japanese type 2 diabetic patients

H. Kanehara, Y. Bando, Keiko Aoki, 2011, Journal of diabetes investigation.

Characteristics of undiagnosed diabetes mellitus in a population undergoing health screening in Japan: target populations for efficient screening.

H. Kanehara, Y. Bando, K. Katoh, 2009, Diabetes research and clinical practice.

Efficacy and Safety of Insulin Glulisine in Intensive Insulin Therapy: Bolus Insulin Adjust Nice Control by apiDRA Study (BANDRA Study)

Yukihiro Bando, Keiko Aoki, Kousuke Shima, 2015 .

Glycated albumin levels are higher relative to HbA1c levels in people with autoimmune acute-onset type 1 diabetes mellitus than in people with type 2 diabetes mellitus at the time of diagnosis.

H. Saito, M. Koga, Y. Bando, 2011, Diabetes research and clinical practice.